SUPN - SUPERNUS PHARMACEUTICALS, INC.
53.87
-0.400 -0.743%
Share volume: 649,634
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$54.27
-0.40
-0.01%
Summary score
75%
Profitability
77%
Dept financing
35%
Liquidity
74%
Performance
85%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
12.41%
Return on assets
6.15%
Return on sales
30.47%
Return on invested capital
29.63%
Total debt ratio
36.36%
Debt ratio change over timeo
0%
Current Ratio
1.88%
Quick Ratio
1.67%
Cash Position Ratio
0.76%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
6.59%
Return on assets
5.95%
Return on sales
29.36%
Return on invested capital
16.5%
Total debt ratio
35.65%
Debt ratio change over timeo
0%
Current Ratio
1.86%
Quick Ratio
1.67%
Cash Position Ratio
0.76%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
6.34%
Return on assets
5.8%
Return on sales
27.79%
Return on invested capital
17.9%
Total debt ratio
34.71%
Debt ratio change over time
0%
Current Ratio
1.82%
Quick Ratio
1.68%
Cash Position Ratio
0.78%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SUPN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 12.41% | 4.12% | 5.6% | 28.84% |
| Return on assets | 6.15% | 2.87% | 3.58% | 3.88% |
| Return on sales | 30.47% | 20.56% | 28.52% | 38.24% |
| Return on invested capital | 29.63% | 4.34% | 6.5% | 4.27% |
| Profitability | 81% | 32% | 44% | 69% |
| Total debt ratio | 36.36% | 63.22% | 51.03% | 91.42% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 35% | 17% | 14% | 25% |
| Current Ratio | 1.86% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 1.67% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 0.76% | 0.31% | 0.62% | 0.55% |
| Liquididy | 72% | 42% | 71% | 61% |
| Short-term ratios | SUPN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 6.59% | 3.9% | 5.53% | 29.97% |
| Return on assets | 5.95% | 2.93% | 3.51% | 3.83% |
| Return on sales | 29.36% | 20.94% | 28.11% | 37.61% |
| Return on invested capital | 16.5% | 4.21% | 6.14% | 4.25% |
| Profitability | 75% | 36% | 47% | 73% |
| Total debt ratio | 35.65% | 64.39% | 51.75% | 91.67% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 35% | 18% | 14% | 25% |
| Current Ratio | 1.86% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 1.67% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 0.76% | 0.31% | 0.62% | 0.55% |
| Liquididy | 74% | 43% | 69% | 60% |